Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients
Condition(s):COVID 19 Associated CoagulopathyLast Updated:January 11, 2023Completed
Hide Studies Not Open or Pending
Condition(s):COVID 19 Associated CoagulopathyLast Updated:January 11, 2023Completed
Condition(s):Gestational DiabetesLast Updated:April 19, 2023Completed
Condition(s):Varicose Veins; MTHFR; Venous Disease; ThrombosisLast Updated:November 17, 2014Completed
Condition(s):Hyperhomocysteinemia, Thrombotic, Cbs-Related; Ischemic Stroke; EpilepsyLast Updated:February 27, 2020Completed
Condition(s):Hyperhomocysteinemia; HyperlipoproteinemiasLast Updated:December 15, 2023Completed
Condition(s):HypertensionLast Updated:April 1, 2022Not yet recruiting
Condition(s):Pediatric Non-Hodgkin LymphomaLast Updated:July 14, 2020Completed
Condition(s):Colon Cancer; MTHFR Gene Mutation; Chemotherapeutic Toxicity; Chemotherapy EffectLast Updated:March 26, 2020Unknown status
Condition(s):High Blood Pressure; MTHFR C677T GenotypeLast Updated:January 27, 2020Terminated
Condition(s):B12 Deficiency Combined With C677T Mutation on MTHFR GeneLast Updated:September 10, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.